Analysis of the European HIV Drugs Market

Analysis of the European HIV Drugs Market

Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

RELEASE DATE
23-Jan-2013
REGION
North America
Deliverable Type
Market Research
Research Code: M8EA-01-00-00-00
SKU: LS00092-NA-MR_16933
AvailableYesPDF Download
$4,950.00
In stock
SKU
LS00092-NA-MR_16933
$4,950.00
DownloadLink
ENQUIRE NOW

Description

This research service provides an in-depth analysis of the HIV drugs market across Europe. It analyses the revenue potential, market dynamics, trends, and the competitive structure. The revenue values of the European HIV drugs market have been derived from market sales and pipeline investment made under drug classes like nucleoside reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and integrase inhibitors. The market analysed in this research service has been approached from a manufacturer's point of view. Apart from segmentation by drug classes, the market has also been broken down based on major Western European countries.

Table of Contents

Executive Summary

Executive Summary—Market Engineering Measurements

Executive Summary—Market Engineering Measurements (continued)

Executive Summary—CEO’s Perspective

Market Overview—Scope of the Study

Market Overview—Definitions

Market Overview—Definitions (continued)

Market Overview—Key Questions This Study Will Answer

Market Overview—Segmentation based on Types of ARV Therapy

Market Overview—Segmentation based on Types of ARV Therapy (continued)

Market Overview—Segmentation based on Geography

Market Overview—Segmentation based on Geography (continued)

Drivers and Restraints

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Impact Mapping of Drivers and Restraints

Market Engineering Measurements

Market Engineering Measurements (continued)

Forecast Assumptions

Total HIV Drugs Market—Revenue Forecast

Total HIV Drugs Market—Revenue Forecast by Segment

Revenue Forecast Discussion

Total HIV Drugs Market—Growth Analysis by Segment

Total HIV Drugs Market—Per cent Revenue Forecast by Region

Total HIV Drugs Market—Revenue Forecast by Region

Regional Revenue Forecast Discussion

HIV Drugs Market—Metrics Analysis

PEST Analysis

Competitive Analysis—Market Share

Market Share Analysis

Market Share Analysis (continued)

Competitive Environment

HIV Drugs Market—Competitive Landscape

Marketed Product Analysis

Marketed Product Analysis (continued)

Marketed Product Analysis (continued)

Key Pipeline Products by Segment

Key Pipeline Products by Segment (continued)

Key Pipeline Products by Segment (continued)

Key Pipeline Products by Segment (continued)

Key Pipeline Products—Analysis

NRTI Segment Overview

NRTI Segment—Market Engineering Measurements

NRTI Segment—Revenue Forecast

NRTI Segment—Revenue Forecast Discussion

NRTI Segment—Metrics Analysis

NRTI Segment—Impact of Key Market Trends

PI Segment Overview

PI Segment—Market Engineering Measurements

PI Segment—Revenue Forecast

PI Segment—Revenue Forecast Discussion

PI Segment—Metrics Analysis

PI Segment—Impact of Key Market Trends

NNRTI Segment Overview

NNRTI Segment—Market Engineering Measurements

NNRTI Segment—Revenue Forecast

NNRTI Segment—Revenue Forecast Discussion

NNRTI Segment—Metrics Analysis

NNRTI Segment—Impact of Key Market Trends

Integrase Inhibitor Segment Overview

Integrase Inhibitor Segment—Market Engineering Measurements

Integrase Inhibitor Segment—Revenue Forecast

Integrase Inhibitor Segment—Revenue Forecast Discussion

Integrase Inhibitor Segment—Metrics Analysis

Integrase Inhibitor Segment—Impact of Key Market Trends

Other Therapeutics Segment Overview

Other Therapeutics Segment—Market Engineering Measurements

Other Therapeutics Segment—Revenue Forecast

Other Therapeutics Segment—Revenue Forecast Discussion

The United Kingdom Market—Introduction

The United Kingdom Market—Market Engineering Measurements

The United Kingdom Market—Revenue Forecast

The United Kingdom Market—Revenue Forecast Discussion

The United Kingdom Market—Key Trends and Implications

Germany Market—Introduction

Germany Market—Market Engineering Measurements

Germany Market—Revenue Forecast

Germany Market—Revenue Forecast Discussion

Germany Market—Key Trends and Implications

France Market—Introduction

France Market—Market Engineering Measurements

France Market—Revenue Forecast

France Market—Revenue Forecast Discussion

France Market—Key Trends and Implications

Spain Market—Introduction

Spain Market—Market Engineering Measurements

Spain Market—Revenue Forecast

Spain Market—Revenue Forecast Discussion

Spain Market—Key Trends and Implications

Italy Market—Introduction

Italy Market—Market Engineering Measurements

Italy Market—Revenue Forecast

Italy Market—Revenue Forecast Discussion

Italy Market—Key Trends and Implications

Belgium Market—Introduction

The Netherlands Market—Introduction

Luxembourg Market—Introduction

Benelux Market—Market Engineering Measurements

Benelux Market—Revenue Forecast

Benelux Market—Revenue Forecast Discussion

Benelux Market—Key Trends and Implications

Denmark Market—Introduction

Norway Market—Introduction

Sweden Market—Introduction

Finland Market—Introduction

Scandinavia Market—Market Engineering Measurements

Scandinavia Market—Revenue Forecast

Scandinavia Market—Revenue Forecast Discussion

Scandinavia Market—Key Trends and Implications

Conclusions—European HIV Drugs Market

The Last Word—Three Big Predictions

Legal Disclaimer

Market Engineering Methodology

Database of Key Industry Participants

Additional Sources of Information

Prevalence of HIV

Incidence of AIDS

Mortality Due to AIDS

Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This research service includes comprehensive information on the market background, analyses of drug development, detailed product and pipeline analyses, detailed product profiles for key marketed/late-stage products, and a global overview. The research service also provides time-sensitive details such as new product launch timelines, PCSK9 Phase 3 programs, and patent expirations.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Author Deepika Pramod Chopda
WIP Number M8EA-01-00-00-00
Is Prebook No